COMPANY
Dxterity Diagnostics Incorporated
Timeline
- Trial start —: ELEVATE - (Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation) source ↗
- Trial start —: COVID-19 Immunity Assessment source ↗
- Trial start —: Exploring the Biological Basis of Chronic Fatigue Syndrome source ↗
- Trial start —: Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response source ↗
- Trial start —: Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy source ↗
- Trial start —: Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization source ↗
- Trial start —: Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) source ↗
- Trial start —: Gene Expression That Predicts Radiation Exposure in Humans source ↗
Clinical trials (lead sponsor) 8
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05347992 | ELEVATE - (Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation) | Not listed | Completed | May 3, 2022 | May 25, 2023 (actual) |
| NCT03133286 | Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) | Not listed | Completed | Apr 6, 2017 | Feb 24, 2020 (actual) |
| NCT03316404 | Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response | Not listed | Completed | Nov 7, 2017 | Feb 24, 2020 (actual) |
| NCT05080231 | COVID-19 Immunity Assessment | Not listed | Completed | Jul 15, 2021 | Sep 10, 2021 (actual) |
| NCT04859257 | Exploring the Biological Basis of Chronic Fatigue Syndrome | Not listed | Completed | May 26, 2021 | Dec 1, 2021 (actual) |
| NCT03123133 | Gene Expression That Predicts Radiation Exposure in Humans | Not listed | Completed | Apr 6, 2017 | Apr 17, 2020 (actual) |
| NCT03142425 | Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy | Not listed | Unknown status (ClinicalTrials.gov) | Jun 19, 2017 | 2019-12 (estimated) |
| NCT03142412 | Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization | Not listed | Unknown status (ClinicalTrials.gov) | Apr 17, 2017 | Oct 17, 2021 (estimated) |